Dermtech Plaplus News Today

Novavax, Inc Novavax, Inc. is a clinical-stage vaccine company that focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. With the onset of the global pandemic last year, the company has also ventured into making COVID-19 vaccines. Despite not having any product in the market yet and facing delays in production, it is still expected to be one of the leading vaccine candidates. The company’s vaccine has proven to be just as potent as o...

The Price And Volume Action In DermTechs Stock Today DermTechs (NASDAQ:DMTK) stock has been rising Tuesday, up 15.75% to a price of $49.28. The stocks volume is currently 2.83 million, which is roughly 208.88% of its recent 30-day volume average of 1.36 million. Why Its Moving Benzinga Pros real-time breaking news service shows some insight into what is affecting shares: DermTech shares are trading higher after the company announced the launch DermTech PLAplusTM, its test for the enhanced early...